Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: J Heart Lung Transplant. 2014 Jun 23;33(12):1215–1222. doi: 10.1016/j.healun.2014.06.007

Figure 2. Effects of ventricular assist device (VAD) placement on serum NGAL, cystatin C and routine markers of renal function.

Figure 2

NGAL (A) and creatinine (C) improve during VAD support in patients with advanced HF (both p<0.05 versus pre-VAD) while cystatin C (B) and eGFR (D) show only a trend towards improvement post-VAD. Individual data shown for matched pairs on the left, average group data shown on the right (n=22 matched pairs, *p<0.05 versus pre-VAD).